Skip to main content

and
  1. Article

    Open Access

    Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers

    The aim of this study was to investigate the expression of the nuclear receptor PPARγ, together with that of the cyclooxygenases Cox-1 and Cox-2, in breast cancer (BC) tissues and to correlate the data with se...

    Wanting Shao, Christina Kuhn, Doris Mayr, Nina Ditsch in Journal of Translational Medicine (2020)

  2. Article

    Open Access

    EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

    In various cancers, overexpression of cyclooxygenase (COX)-2 and elevated prostaglandin (PG) E2 synthesis have been associated with tumor development and progression. The potential of COX-2 inhibitors in cance...

    Anna Semmlinger, Viktoria von Schoenfeldt, Verena Wolf, Alexandra Meuter in BMC Cancer (2018)

  3. Article

    Open Access

    Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids

    Targeted anti-HER2 therapy has greatly improved the prognosis for many breast cancer patients. However, treatment for HER2 negative disease is currently still selected from a multitude of untargeted chemothera...

    Kathrin Halfter, Oliver Hoffmann, Nina Ditsch in Journal of Translational Medicine (2016)

  4. No Access

    Article

    LIFESTYLE und erblicher Brustkrebs

    Nicht für alle Trägerinnen einer Mutation in den Genen BRCA1 und BRCA2 liegt das lebenslange Erkrankungsrisiko für Brust- oder Eierstockkrebs gleich hoch. Bislang werden jedoch bei der Indikationsstellung zur Tei...

    Dr. Karin Kast, Nina Ditsch, Marion Kiechle in medizinische genetik (2015)

  5. Article

    Open Access

    Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study

    Aim of this prospective study was to predict response to neoadjuvant therapy in breast cancer patients using an in vitro breast cancer spheroid model.

    Kathrin Halfter, Nina Ditsch, Hans-Christian Kolberg, Holger Fischer in BMC Cancer (2015)

  6. No Access

    Article

    Effect of optical clearing agents on optical coherence tomography images of cervical epithelium

    Optical coherence tomography (OCT) can be used as an adjunct to colposcopy in order to detect precancerous and cancerous cervical lesions. Optical clearing agents (OCAs) temporarily reduce the optical scatteri...

    Julia Gallwas, Anna Stanchi, Nina Ditsch, Theresa Schwarz in Lasers in Medical Science (2015)

  7. No Access

    Article

    Effect of acetic acid on optical coherence tomography (OCT) images of cervical epithelium

    Optical coherence tomography (OCT) can be used as an adjunct to colposcopy in the identification of precancerous and cancerous cervical lesions. The purpose of this study was to investigate the effect of aceti...

    Julia Gallwas, Anna Stanchi, Christian Dannecker, Nina Ditsch in Lasers in Medical Science (2014)

  8. Article

    Open Access

    Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer

    Knowledge on immunosuppressive factors in the pathogenesis of endometrial cancer is scarce. The aim of this study was to assess Glycodelin (Gd) and its immunosuppressive isoform Glycodelin A (GdA) in endometri...

    Miriam Lenhard, Sabine Heublein, Christiane Kunert-Keil, Thomas Vrekoussis in BMC Cancer (2013)

  9. Article

    Open Access

    Multicentric and multifocal versusunifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology

    The aim of this study was to evaluate the expression of the cell adhesion-related glycoproteins MUC-1, β-catenin and E-cadherin in multicentric/multifocal breast cancer in comparison to unifocal disease in ord...

    Tobias Weissenbacher, Eva Hirte, Christina Kuhn, Wolfgang Janni, Doris Mayr in BMC Cancer (2013)

  10. Article

    Open Access

    Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival

    There is partially conflicting evidence on the influence of the steroid hormones estrogen (E) and progesterone (P) on the development of ovarian cancer (OC). The aim of this study was to assess the expression ...

    Miriam Lenhard, Lennerová Tereza, Sabine Heublein, Nina Ditsch in BMC Cancer (2012)

  11. Article

    Open Access

    Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer

    An influence of gonadotropins (hCG) on the development of ovarian cancer has been discussed. Therefore, we quantified serum hCG levels in patients with benign and malignant ovarian tumors and the hCG expressio...

    Miriam Lenhard, Alexandra Tsvilina, Lan Schumacher, Markus Kupka, Nina Ditsch in BMC Cancer (2012)

  12. Article

    Open Access

    Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

    Coregulator proteins are "master regulators", directing transcriptional and posttranscriptional regulation of many target genes, and are critical in many normal physiological processes, but also in hormone dri...

    Ryan J Hartmaier, Sandrine Tchatchou, Alexandra S Richter, Jay Wang in BMC Cancer (2009)